Tomoko Kurita

8PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
Survival and Safety Outcomes of Three-Cycle Adjuvant Chemotherapy in Intermediate-Risk Endometrial Cancer.

|Dec 30, 2025
Low Neutrophil-to-Lymphocyte Ratio Combined with High Intraepithelial CD8+ Tumour-Infiltrating Lymphocytes Within the Tumour Microenvironment Is a Prominent Prognostic Factor in Advanced Epithelial Ovarian Cancer.

Mami Shibahara, Hiroshi Harada, Tomoko Kurita

|Feb 26, 2025
Intra-Tumoral Lymphocytic Infiltration Is Associated with Favorable Prognosis in Suboptimal Surgery in High-Grade Serous Ovarian Carcinoma.

Hiroshi Harada, Toru Hachisuga, Yoshikazu Harada

|Oct 27, 2023
Local Treatment Efficacy for Single-Area Squamous Cell Carcinoma of the Unknown Primary Site.

Tomoko Kurita, Mayu Yunokawa, Yuji Tanaka

|Aug 21, 2023
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015.

Kiyoshi Yoshino, Tomoko Kurita, Fumiaki Takahashi

|May 28, 2022
Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.

Kiyoshi Yoshino, Tomoko Kurita, Fumiaki Takahashi

Pageof 2

Frequent Collaborators

3 joint publications

Kiyoshi Yoshino

3 joint publications

Toru Hachisuga

2 joint publications

Yoshikazu Harada

2 joint publications

Shota Higami